These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34909350)

  • 1. Quality of Life of Patients With Hidradenitis Suppurativa in Jeddah, Saudi Arabia.
    Alamri AM; Alzahrani AA; Aldakhil AM; Alharbi HE; Yahya FA
    Cureus; 2021 Dec; 13(12):e20234. PubMed ID: 34909350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data.
    Kyriakou A; Trigoni A; Galanis N; Sotiriadis D; Patsatsi A
    Dermatol Reports; 2018 Oct; 10(2):7859. PubMed ID: 30370041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
    Agarwal P; Lunge SB; Shetty NS; Karagaiah P; Daveluy S; Ortega-Loayza AG; Tzellos T; Szepietowski JC; Zouboulis CC; Grabbe S; Goldust M
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Real-World Application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) Score to Adults with Hidradenitis Suppurativa.
    Garg A; Burge R; Cohee A; Wallinger H; Truman I; Keal A; Strunk A; Barlow S
    Br J Dermatol; 2024 Oct; ():. PubMed ID: 39374841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.
    Alavi A; Anooshirvani N; Kim WB; Coutts P; Sibbald RG
    Am J Clin Dermatol; 2015 Feb; 16(1):61-5. PubMed ID: 25432664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
    Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the psychological burden of patients with hidradenitis suppurativa.
    Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
    Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity in patients with hidradenitis suppurativa.
    von der Werth JM; Jemec GB
    Br J Dermatol; 2001 Apr; 144(4):809-13. PubMed ID: 11298541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial Implications and Quality of Life in Patients with Hidradenitis Suppurativa Compared to Those With Atopic Dermatitis and Psoriasis: a Cross-sectional Case-control Study.
    Alya A; Saleh A; Sawsan A; Louai S
    Dermatol Pract Concept; 2023 Apr; 13(2):. PubMed ID: 37196280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.